Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Kelley, Robin
Item TypeName
Concept Liver
Concept Liver Cirrhosis
Concept Liver Diseases
Concept Liver Function Tests
Concept Liver Neoplasms
Concept Liver Transplantation
Academic Article Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study.
Academic Article Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
Academic Article Can we cure cholangiocarcinoma with neoadjuvant chemoradiation and liver transplantation? Time for a multicenter trial.
Academic Article The evolving role of combination systemic therapies in hepatocellular carcinoma.
Academic Article Hepatocellular Carcinoma - Origins and Outcomes.
Academic Article Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma.
Academic Article Novel therapeutics in hepatocellular carcinoma: how can we make progress?
Academic Article Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response.
Academic Article Brivanib and FOLFOX in hepatocellular carcinoma: finding the common themes among negative trials.
Academic Article Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma.
Academic Article Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design.
Academic Article Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma.
Academic Article Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-?RI inhibitor galunisertib.
Academic Article Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.
Academic Article Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.
Academic Article Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series.
Academic Article Adjuvant sorafenib for liver cancer: wrong stage, wrong dose.
Academic Article Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma.
Academic Article Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA.
Academic Article Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling.
Academic Article Sorafenib in hepatocellular carcinoma: separating the hype from the hope.
Academic Article Heterogeneous Uptake of 18F-FDG and 68Ga-PSMA-11 in Hepatocellular Carcinoma.
Academic Article Emerging Role for Systemic Therapy in Earlier Stages of HCC.
Academic Article Cases of spontaneous tumor regression in hepatobiliary cancers: implications for immunotherapy?
Academic Article Atezolizumab plus Bevacizumab - A Landmark in Liver Cancer.
Academic Article Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
Academic Article Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma.
Academic Article Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
Academic Article Cabozantinib in Hepatocellular Carcinoma.
Academic Article Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade.
Academic Article Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial.
Academic Article Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma.
Academic Article Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy.
Academic Article Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer).
Search Criteria
  • Liver